Jeevan Scientific Technology (BSE:538837) - Share price, News & Analysis

538837 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	6/6
Financial Health	6/6
Dividends	3/6

538837 Stock Overview

Jeevan Scientific Technology Limited engages in the clinical research, data management, and information technology businesses in India.

Rewards

Trading at 53.6% below our estimate of its fair value

Earnings grew by 532.2% over the past year

Risk Analysis

Unstable dividend track record

Does not have a meaningful market cap (₹1B)

Jeevan Scientific Technology Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jeevan Scientific Technology
Historical stock prices
Current Share Price	₹81.90
52 Week High	₹229.45
52 Week Low	₹70.85
Beta	1.11
1 Month Change	-44.77%
3 Month Change	-51.28%
1 Year Change	-12.08%
3 Year Change	173.46%
5 Year Change	133.33%
Change since IPO	213.19%

Shareholder Returns

	538837	IN Life Sciences	IN Market
7D	-2.6%	-0.3%	0.7%
1Y	-12.1%	4.0%	10.6%

Return vs Industry: 538837 underperformed the Indian Life Sciences industry which returned 1.6% over the past year.

Return vs Market: 538837 underperformed the Indian Market which returned 9% over the past year.

Price Volatility

Is 538837's price volatile compared to industry and market?
538837 volatility
538837 Average Weekly Movement	8.4%
Life Sciences Industry Average Movement	7.4%
Market Average Movement	7.2%
10% most volatile stocks in IN Market	10.0%
10% least volatile stocks in IN Market	4.8%

Stable Share Price: 538837 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 538837's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1999	251	Snigdha Mothukuri	https://www.jeevanscientific.com

Jeevan Scientific Technology Limited engages in the clinical research, data management, and information technology businesses in India. The company’s services include BA/BE studies that comprise bioanalytical and clinical services, pharmacokinetic and bio-statistics, and glucose clamping; clinical trial services, such as medical writing, clinical trial management and monitoring, drug safety and clinical data management, biostatistics and statistical programming, and quality assurance; and pharmacovigilance services, including ICSR management, aggregate safety reports, risk management plan, signal detection, medical information call center, and other integrated services. It also provides services in the areas of test assessment, test center of excellence, process establishment, and functional and non-functional testing.

Jeevan Scientific Technology Fundamentals Summary

How do Jeevan Scientific Technology's earnings and revenue compare to its market cap?
538837 fundamental statistics
Market Cap	₹1.25b
Earnings (TTM)	₹151.71m
Revenue (TTM)	₹703.19m

8.3x

P/E Ratio

1.8x

P/S Ratio

Is 538837 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
538837 income statement (TTM)
Revenue	₹703.19m
Cost of Revenue	₹73.71m
Gross Profit	₹629.49m
Other Expenses	₹477.78m
Earnings	₹151.71m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	9.91
Gross Margin	89.52%
Net Profit Margin	21.57%
Debt/Equity Ratio	24.0%

How did 538837 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

5%

Payout Ratio

Valuation

Is Jeevan Scientific Technology undervalued compared to its fair value and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 538837 (₹81.9) is trading below our estimate of fair value (₹176.52)

Significantly Below Fair Value: 538837 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: 538837 is good value based on its PE Ratio (8.3x) compared to the Indian Life Sciences industry average (39.3x).

PE vs Market: 538837 is good value based on its PE Ratio (8.3x) compared to the Indian market (20.1x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 538837's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 538837 is overvalued based on its PB Ratio (3x) compared to the IN Life Sciences industry average (2.8x).

Future Growth

How is Jeevan Scientific Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

22.4%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jeevan Scientific Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Jeevan Scientific Technology performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

44.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 538837 has high quality earnings.

Growing Profit Margin: 538837's current net profit margins (21.6%) are higher than last year (5.8%).

Past Earnings Growth Analysis

Earnings Trend: 538837 has become profitable over the past 5 years, growing earnings by 44.6% per year.

Accelerating Growth: 538837's earnings growth over the past year (532.2%) exceeds its 5-year average (44.6% per year).

Earnings vs Industry: 538837 earnings growth over the past year (532.2%) exceeded the Life Sciences industry -2.2%.

Return on Equity

High ROE: 538837's Return on Equity (36%) is considered high.

Financial Health

How is Jeevan Scientific Technology's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: 538837's short term assets (₹421.5M) exceed its short term liabilities (₹234.7M).

Long Term Liabilities: 538837's short term assets (₹421.5M) exceed its long term liabilities (₹69.5M).

Debt to Equity History and Analysis

Debt Level: 538837 has more cash than its total debt.

Reducing Debt: 538837's debt to equity ratio has reduced from 360.8% to 24% over the past 5 years.

Debt Coverage: 538837's debt is well covered by operating cash flow (146.8%).

Interest Coverage: 538837's interest payments on its debt are well covered by EBIT (38.6x coverage).

Balance Sheet

Dividend

What is Jeevan Scientific Technology current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

0.61%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 538837's dividend (0.61%) is higher than the bottom 25% of dividend payers in the Indian market (0.37%).

High Dividend: 538837's dividend (0.61%) is low compared to the top 25% of dividend payers in the Indian market (1.61%).

Stability and Growth of Payments

Stable Dividend: Too early to tell whether 538837's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 538837's dividend payments are increasing as they only just started paying a dividend.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (5%), 538837's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (5.6%), 538837's dividend payments are thoroughly covered by cash flows.

Next Steps

Explore strong dividend paying companies in the Pharmaceuticals & Biotech industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

1.1yrs

Average management tenure

CEO

Snigdha Mothukuri (29 yo)

0.92

Tenure

₹1,000,000

Compensation

Mrs. Snigdha Mothukuri has been Chief Executive Officer of Jeevan Scientific Technology Limited since June 23, 2021 and also its Executive Director since November 02, 2020. She is an enthusiastic honors gr...

CEO Compensation Analysis

Compensation vs Market: Snigdha's total compensation ($USD12.85K) is below average for companies of similar size in the Indian market ($USD38.73K).

Compensation vs Earnings: Insufficient data to compare Snigdha's compensation with company performance.

Leadership Team

Experienced Management: 538837's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

Experienced Board: 538837's board of directors are considered experienced (3.9 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/17 00:00
End of Day Share Price	2022/05/17 00:00
Earnings	2021/12/31
Annual Earnings	2021/03/31